Core features of frontotemporal dementia recapitulated in progranulin knockout mice

被引:87
|
作者
Ghoshal, N. [1 ]
Dearborn, J. T. [2 ]
Wozniak, D. F. [2 ]
Cairns, N. J. [1 ,3 ]
机构
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
Frontotemporal lobar degeneration; Frontotemporal dementia; Knockout mouse; Neurodegeneration; Social behavior; Memory; Ubiquitin; Progranulin; LOBAR DEGENERATION; ALZHEIMERS-DISEASE; DEFICIENT MICE; GENE; MUTATIONS; INCLUSIONS; LACKING; CONSENSUS; CRITERIA; CULTURES;
D O I
10.1016/j.nbd.2011.08.029
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Frontotemporal dementia (FTD) is typified by behavioral and cognitive changes manifested as altered social comportment and impaired memory performance. To investigate the neurodegenerative consequences of progranulin gene (GRN) mutations, which cause an inherited form of FTD, we used previously generated progranulin knockout mice (Grn-/-). Specifically, we characterized two cohorts of early and later middle-aged wild type and knockout mice using a battery of tests to assess neurological integrity and behavioral phenotypes analogous to FTD. The Grn-/- mice exhibited reduced social engagement and learning and memory deficits. Immunohistochemical approaches were used to demonstrate the presence of lesions characteristic of frontotemporal lobar degeneration (FTLD) with GRN mutation including ubiquitination, microgliosis, and reactive astrocytosis, the pathological substrate of FTD. Importantly, Grn-/- mice also have decreased overall survival compared to Grn+/+ mice. These data suggest that the Grn-/- mouse reproduces some core features of FTD with respect to behavior, pathology, and survival. This murine model may serve as a valuable in vivo model of FTLD with GRN mutation through which molecular mechanisms underlying the disease can be further dissected. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:395 / 408
页数:14
相关论文
共 50 条
  • [1] Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia
    Wilke, Carlo
    Gillardon, Frank
    Deuschle, Christian
    Hobert, Markus A.
    Jansen, Iris E.
    Metzger, Florian G.
    Heutink, Peter
    Gasser, Thomas
    Maetzler, Walter
    Blauwendraat, Cornelis
    Synofzik, Matthis
    NEURODEGENERATIVE DISEASES, 2017, 17 (2-3) : 83 - 88
  • [2] Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia
    Holler, Christopher J.
    Taylor, Georgia
    McEachin, Zachary T.
    Deng, Qiudong
    Watkins, William J.
    Hudson, Kathryn
    Easley, Charles A.
    Hu, William T.
    Hales, Chadwick M.
    Rossoll, Wilfried
    Bassell, Gary J.
    Kukar, Thomas
    MOLECULAR NEURODEGENERATION, 2016, 11
  • [3] Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members
    Finch, NiCole
    Baker, Matt
    Crook, Richard
    Swanson, Katie
    Kuntz, Karen
    Surtees, Rebecca
    Bisceglio, Gina
    Rovelet-Lecrux, Anne
    Boeve, Bradley
    Petersen, Ronald C.
    Dickson, Dennis W.
    Younkin, Steven G.
    Deramecourt, Vincent
    Crook, Julia
    Graff-Radford, Neill R.
    Rademakers, Rosa
    BRAIN, 2009, 132 : 583 - 591
  • [4] Frontotemporal dementia in a large Swedish family is caused by a progranulin null mutation
    Skoglund, Lena
    Brundin, RoseMarie
    Olofsson, Tommie
    Kalimo, Hannu
    Ingvast, Sofie
    Blom, Elin S.
    Giedraitis, Vilmantas
    Ingelsson, Martin
    Lannfelt, Lars
    Basun, Hans
    Glaser, Anna
    NEUROGENETICS, 2009, 10 (01) : 27 - 34
  • [5] Behavioral deficits and progressive neuropathology in progranulin-deficient mice: a mouse model of frontotemporal dementia
    Yin, Fangfang
    Dumont, Magali
    Banerjee, Rebecca
    Ma, Yao
    Li, Huihong
    Lin, Michael T.
    Beal, M. Flint
    Nathan, Carl
    Thomas, Bobby
    Ding, Aihao
    FASEB JOURNAL, 2010, 24 (12) : 4639 - 4647
  • [6] Recent Insights into the Involvement of Progranulin in Frontotemporal Dementia
    Sun, Li
    Eriksen, Jason L.
    CURRENT NEUROPHARMACOLOGY, 2011, 9 (04) : 632 - 642
  • [7] Loss of exosomes in progranulin-associated frontotemporal dementia
    Benussi, Luisa
    Ciani, Miriam
    Tonoli, Elisa
    Morbin, Michela
    Palamara, Luisa
    Albani, Diego
    Fusco, Federica
    Forloni, Gianluigi
    Glionna, Michela
    Baco, Monika
    Paterlini, Anna
    Fostinelli, Silvia
    Santini, Benedetta
    Galbiati, Elisabetta
    Gagni, Paola
    Cretich, Marina
    Binetti, Giuliano
    Tagliavini, Fabrizio
    Prosperi, Davide
    Chiari, Marcella
    Ghidoni, Roberta
    NEUROBIOLOGY OF AGING, 2016, 40 : 41 - 49
  • [8] Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia
    Kurnellas, Michael
    Mitra, Ananya
    Schwabe, Tina
    Paul, Robert
    Arrant, Andrew E.
    Roberson, Erik D.
    Ward, Michael
    Yeh, Felix
    Long, Hua
    Rosenthal, Arnon
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [9] Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice
    Frew, Jonathan
    Nygaard, Haakon Berge
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2021, 9 (01)
  • [10] Frontotemporal dementia and parkinsonism associated with the IVSI plus IG→A mutation in progranulin:: a clinicopathologic study
    Boeve, Bradley F.
    Baker, Matt
    Dickson, Dennis W.
    Parisi, Joseph E.
    Giannini, Caterina
    Josephs, Keith A.
    Hutton, Michael
    Pickering-Brown, Stuart M.
    Rademakers, Rosa
    Tang-Wai, David
    Jack, Clifford R., Jr.
    Kantarci, Kejal
    Shiung, Maria M.
    Golde, Todd
    Smith, Glenn E.
    Geda, Yonas E.
    Knopman, David S.
    Petersen, Ronald C.
    BRAIN, 2006, 129 : 3103 - 3114